title: [Clinical analysis of thalidomide in 36 untreated patients with T-cell lymphoma].
authors.forename: H Y
authors.initials: HY
authors.lastname: Huang
authors.forename: Y Q
authors.initials: YQ
authors.lastname: Song
authors.forename: W
authors.initials: W
authors.lastname: Zheng
authors.forename: X P
authors.initials: XP
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Xie
authors.forename: N J
authors.initials: NJ
authors.lastname: Lin
authors.forename: M F
authors.initials: MF
authors.lastname: Tu
authors.forename: C
authors.initials: C
authors.lastname: Zhang
authors.forename: L Y
authors.initials: LY
authors.lastname: Ping
authors.forename: W P
authors.initials: WP
authors.lastname: Liu
authors.forename: Z T
authors.initials: ZT
authors.lastname: Ying
authors.forename: L J
authors.initials: LJ
authors.lastname: Deng
authors.forename: N
authors.initials: N
authors.lastname: Ding
authors.forename: M
authors.initials: M
authors.lastname: Wu
authors.forename: Y L
authors.initials: YL
authors.lastname: Sun
authors.forename: T T
authors.initials: TT
authors.lastname: Du
authors.forename: X
authors.initials: X
authors.lastname: Leng
authors.forename: J
authors.initials: J
authors.lastname: Zhu
mesh_terms: D006801:Humans; D016399:Lymphoma, T-Cell / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide